Status:
COMPLETED
Effects of Drugs on Responses to Brain and Emotional Processes
Lead Sponsor:
University of Chicago
Conditions:
Autism Spectrum Disorder
Healthy
Eligibility:
All Genders
21-40 years
Phase:
EARLY_PHASE1
Brief Summary
To study the effects of a psychostimulant on responses to affective touch in individuals with a range of autistic traits
Eligibility Criteria
Inclusion
- BMI between 19 and 30 (no one under 130 lbs)
- Smokers smoking less than 25 cigarettes per week
- Have used ecstasy no more than 40 times with no adverse responses.
Exclusion
- High blood pressure
- Any medical condition requiring regular medication
- Individuals with a current (within the last year) DSM-IV Axis 1 diagnosis
- Individuals with a history of dependence on stimulant drugs.
- Women who are pregnant or trying to become pregnant
Key Trial Info
Start Date :
August 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04053036
Start Date
August 8 2019
End Date
April 12 2021
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637